Sometimes last month feels like a long time ago, but considering our planet, the long perspective can really help.

NT-112 is under clinical development by Neogene Therapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate ...

Neogene Therapeutics, a subsidiary of AstraZeneca Plc, operates as a pre-clinical stage biotechnology company that is engaged in the development, and manufacturing T cell receptor therapies for solid ...

Sharks have ruled the Earth’s oceans for 400 million years and recent research on fossilized shark teeth has led to the ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

The bone fragments of Lucy, a 3.18 million year-old human ancestor which rarely leave Ethiopia, will go on display in Europe ...

The Sutlej River Basin isn’t just a geographical feature; it’s the pulse of Punjab, threading through its heartland, shaping its fields, feeding its people, dictating the rhythm of life in ways both ...

Additionally, studies have explored the evolution of porewater in Neogene sedimentary formations, focusing on the concept of "fossil seawater." This ancient seawater, trapped in deep sedimentary ...

Introduction: While the biodiversity value of springs is recognised, it has not been systematically compiled. The aim of the current study is to highlight the extraordinary endemism associated with ...

Syncona Ltd (”Syncona”), a leading life science investor focused on creating, building and scaling a portfolio of global leaders in life science, today issues its quarterly update covering the period ...